These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 2530773

  • 21. A new antidepressant agent: amitriptyline-N-oxide.
    Borromei A.
    Adv Biochem Psychopharmacol; 1982; 32():43-7. PubMed ID: 7046367
    [No Abstract] [Full Text] [Related]

  • 22. Cardiovascular effects of paroxetine.
    Kuhs H, Rudolf GA.
    Psychopharmacology (Berl); 1990; 102(3):379-82. PubMed ID: 2147517
    [Abstract] [Full Text] [Related]

  • 23. The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo.
    Peselow ED, Filippi AM, Goodnick P, Barouche F, Fieve RR.
    Psychopharmacol Bull; 1989; 25(2):267-71. PubMed ID: 2532373
    [No Abstract] [Full Text] [Related]

  • 24. A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients.
    Rickels K, Amsterdam J, Clary C, Fox I, Schweizer E, Weise C.
    Acta Psychiatr Scand Suppl; 1989; 350():117-23. PubMed ID: 2530761
    [Abstract] [Full Text] [Related]

  • 25. Introduction to the development of paroxetine, a novel antidepressant.
    Lassen JB.
    Acta Psychiatr Scand Suppl; 1989; 350():13. PubMed ID: 2530764
    [No Abstract] [Full Text] [Related]

  • 26. A double-blind study of minaprine versus amitriptyline in major depression.
    Del Zompo M, Bernardi F, Burrai C, Bocchetta A.
    Neuropsychobiology; 1989; 24(2):79-83. PubMed ID: 2134115
    [Abstract] [Full Text] [Related]

  • 27. A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
    Kiev A.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():27-9. PubMed ID: 1531818
    [Abstract] [Full Text] [Related]

  • 28. Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients.
    Möller HJ, Berzewski H, Eckmann F, Gonzalves N, Kissling W, Knorr W, Ressler P, Rudolf GA, Steinmeyer EM, Magyar I.
    Pharmacopsychiatry; 1993 May; 26(3):75-8. PubMed ID: 8415897
    [Abstract] [Full Text] [Related]

  • 29. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
    Dechant KL, Clissold SP.
    Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
    [Abstract] [Full Text] [Related]

  • 30. A comparative double-blind controlled study of trimipramine and amitriptyline in major depression: lack of correlation with 5-hydroxytryptamine reuptake blockade.
    Cournoyer G, de Montigny C, Ouellette J, Langlois R, Elie R, Caille G, le Morvan P.
    J Clin Psychopharmacol; 1987 Dec; 7(6):385-93. PubMed ID: 3323262
    [Abstract] [Full Text] [Related]

  • 31. Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements.
    Nielsen OA, Morsing I, Petersen JS, Larsen T, Møller SE, Manniche PM, Skausig OB.
    Acta Psychiatr Scand; 1991 Sep; 84(3):233-41. PubMed ID: 1835251
    [Abstract] [Full Text] [Related]

  • 32. A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients. Italian Paroxetine Study Group.
    Bignamini A, Rapisarda V.
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():37-41. PubMed ID: 1431009
    [Abstract] [Full Text] [Related]

  • 33. An overview of paroxetine.
    Boyer WF, Feighner JP.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():3-6. PubMed ID: 1531819
    [Abstract] [Full Text] [Related]

  • 34. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB, Crowder JE, Wilcox CS, Ryan PJ.
    Psychopharmacol Bull; 1990 Feb; 26(2):185-9. PubMed ID: 2146697
    [Abstract] [Full Text] [Related]

  • 35. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP, Boyer WF.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [Abstract] [Full Text] [Related]

  • 36. Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline.
    Montgomery SA, Montgomery DB, McAuley R, Rani SJ, Roy D.
    Adv Biochem Psychopharmacol; 1982 Feb; 32():35-42. PubMed ID: 6211942
    [No Abstract] [Full Text] [Related]

  • 37. Controlled comparison of nefazodone and amitriptyline in major depressive inpatients.
    Ansseau M, Darimont P, Lecoq A, De Nayer A, Evrard JL, Krémer P, Devoitille JM, Dierick M, Mertens C, Mesotten F.
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):254-60. PubMed ID: 7862904
    [Abstract] [Full Text] [Related]

  • 38. Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder".
    Hashimoto K.
    J Clin Psychopharmacol; 2009 Aug; 29(4):411-2; author reply 412. PubMed ID: 19593196
    [No Abstract] [Full Text] [Related]

  • 39. A double-blind comparison of clovoxamine and amitriptyline in the treatment of depressed outpatients.
    Gelenberg AJ, Wojcik JD, Newell C, Lamping DL, Spring B.
    J Clin Psychopharmacol; 1985 Feb; 5(1):30-4. PubMed ID: 3882774
    [Abstract] [Full Text] [Related]

  • 40. A double blind comparison of zimelidine and amitriptyline in endogenous depression.
    Montgomery SA, McAuley R, Rani SJ, Roy D, Montgomery DB.
    Acta Psychiatr Scand Suppl; 1981 Feb; 290():314-27. PubMed ID: 6452798
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.